|
|
|
|
|
|
by ceejayoz
2149 days ago
|
|
|
> Would there not be value in pre-screening patients for SCN9A mutations to predict an increased risk of pain killer addiction? Dangers, too. Legitimate pain patients already frequently have to drop through an onerous set of hoops for opiates, and the medical system isn't always good at teasing out "increased risk" from "unacceptable risk". (For example: https://en.wikipedia.org/wiki/Rofecoxib, aka Vioxx) |
|
|